Submit a Manuscript to the Journal
International Journal of Nanomedicine
For an Article Collection on
Gamechanger Series: Transformative Applications of Lipid Nanoparticles in mRNA Therapeutics
Manuscript deadline
Article Collection Guest Advisor(s)
Prof. Dr. RDK Misra, Editor in Chief,
University of Texas at El Paso, USA
[email protected]
Gamechanger Series: Transformative Applications of Lipid Nanoparticles in mRNA Therapeutics
We are pleased to announce a new Article Collection in the International Journal of Nanomedicine, dedicated to the game-changing role of lipid nanoparticles (LNP) in the area of mRNA Therapeutics. Since their clinical introduction, mRNA-LNP therapeutics have revolutionized patient care, offering significant benefits in speed of development, therapeutic efficacy, and targeted delivery for eligible patients.
Given the global importance of mRNA-LNP vaccines in COVID-19, and their potential for use in other infectious diseases, cancer, and genetic disorders, the International Journal of Nanomedicine is inviting submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.
The Collection, edited by Editor-In-Chief Prof. RDK Misra, will be included in Taylor and Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
While the call is open to receive manuscripts across the broad spectrum of LNP in mRNA therapeutics, the Editors are particularly interested in manuscripts relating to the following areas:
- Novel lipid nanoparticle formulations and characterization
- Optimization of mRNA delivery systems and targeting strategies
- Scalable manufacturing processes & stability optimization
- mRNA-based vaccines for infectious disease
- mRNA-based therapies for genetic diseases including metabolic disorders, hemophilia, and neurological conditions
- Cancer vaccines and immunotherapies
Please review the journal’s aims and scope and author submission instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code 0BEC2 for a 20% discount on the publishing fee and to indicate that your submission is for consideration in this Article Collection.
Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this Collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.